HealthInvest Partners AB
Latest statistics and disclosures from HealthInvest Partners AB's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LLY, UNH, ABBV, BSX, TMO, and represent 42.35% of HealthInvest Partners AB's stock portfolio.
- Added to shares of these 10 stocks: ABBV (+$8.1M), LLY (+$5.0M), BSX, RVMD, EW, JANX, Beigene, VRTX, TMO, BBIO.
- Started 3 new stock positions in JANX, Beigene, RVMD.
- Reduced shares in these 10 stocks: , MRK, IONS, IMCR, ITCI, HRMY, COR, MIRM, AMGN, UNH.
- Sold out of its positions in IMCR, IONS, REGN.
- HealthInvest Partners AB was a net buyer of stock by $17M.
- HealthInvest Partners AB has $211M in assets under management (AUM), dropping by -0.90%.
- Central Index Key (CIK): 0001381843
Tip: Access up to 7 years of quarterly data
Positions held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 36 positions in its portfolio as reported in the December 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Eli Lilly & Co. (LLY) | 13.6 | $29M | +21% | 37k | 773.84 |
|
UnitedHealth (UNH) | 8.5 | $18M | 35k | 507.80 |
|
|
Abbvie (ABBV) | 7.6 | $16M | +103% | 91k | 176.20 |
|
Boston Scientific Corporation (BSX) | 6.6 | $14M | +45% | 154k | 89.68 |
|
Thermo Fisher Scientific (TMO) | 6.1 | $13M | +13% | 25k | 518.84 |
|
Merck & Co (MRK) | 4.9 | $10M | -31% | 106k | 98.37 |
|
Stryker Corporation (SYK) | 4.4 | $9.3M | +9% | 26k | 362.26 |
|
Neurocrine Biosciences (NBIX) | 4.4 | $9.3M | +11% | 68k | 137.06 |
|
Alkermes SHS (ALKS) | 3.6 | $7.7M | +12% | 267k | 28.78 |
|
Vertex Pharmaceuticals Incorporated (VRTX) | 3.6 | $7.6M | +30% | 22k | 341.27 |
|
AmerisourceBergen (COR) | 3.5 | $7.3M | -10% | 33k | 224.71 |
|
Amgen (AMGN) | 3.4 | $7.1M | -5% | 27k | 259.30 |
|
Intra Cellular Therapies (ITCI) | 2.8 | $5.9M | -15% | 71k | 83.48 |
|
Edwards Lifesciences (EW) | 2.4 | $5.1M | +87% | 68k | 74.24 |
|
Mirum Pharmaceuticals (MIRM) | 2.3 | $4.8M | -15% | 117k | 41.18 |
|
Dex (DXCM) | 2.2 | $4.7M | +11% | 60k | 78.00 |
|
Harmony Biosciences Hldgs In (HRMY) | 1.9 | $4.1M | -20% | 121k | 34.06 |
|
Cardinal Health (CAH) | 1.7 | $3.6M | +11% | 31k | 117.92 |
|
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.7 | $3.6M | 139k | 25.60 |
|
|
Arcellx Common Stock (ACLX) | 1.6 | $3.3M | +4% | 42k | 78.35 |
|
UFP Technologies (UFPT) | 1.5 | $3.2M | +28% | 23k | 136.68 |
|
Amicus Therapeutics (FOLD) | 1.5 | $3.1M | +18% | 327k | 9.41 |
|
Bridgebio Pharma (BBIO) | 1.3 | $2.8M | +92% | 103k | 27.32 |
|
Revolution Medicines (RVMD) | 1.3 | $2.7M | NEW | 62k | 43.17 |
|
Merus N V (MRUS) | 1.2 | $2.6M | +23% | 63k | 41.89 |
|
Janux Therapeutics (JANX) | 1.0 | $2.1M | NEW | 40k | 52.50 |
|
Beigene Sponsored Adr | 1.0 | $2.0M | NEW | 11k | 183.81 |
|
Krystal Biotech (KRYS) | 0.7 | $1.5M | 9.2k | 159.80 |
|
|
Mereo Biopharma Group Spon Ads (MREO) | 0.7 | $1.4M | +95% | 390k | 3.52 |
|
Summit Therapeutics (SMMT) | 0.6 | $1.3M | +17% | 101k | 12.99 |
|
Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.6 | $1.2M | +41% | 98k | 12.08 |
|
Autolus Therapeutics Spon Ads (AUTL) | 0.5 | $1.1M | +8% | 480k | 2.21 |
|
Soleno Therapeutics (SLNO) | 0.5 | $985k | +17% | 31k | 31.83 |
|
Mersana Therapeutics (MRSN) | 0.4 | $765k | 539k | 1.42 |
|
|
Pharvaris N V (PHVS) | 0.3 | $653k | 34k | 19.02 |
|
|
Cabaletta Bio (CABA) | 0.3 | $554k | +46% | 248k | 2.24 |
|
Past Filings by HealthInvest Partners AB
SEC 13F filings are viewable for HealthInvest Partners AB going back to 2013
- HealthInvest Partners AB 2024 Q4 filed Feb. 4, 2025
- HealthInvest Partners AB 2024 Q3 filed Nov. 12, 2024
- HealthInvest Partners AB 2024 Q1 filed April 25, 2024
- HealthInvest Partners AB 2023 Q4 filed Jan. 30, 2024
- HealthInvest Partners AB 2022 Q4 filed Feb. 14, 2023
- HealthInvest Partners AB 2022 Q3 filed Oct. 21, 2022
- HealthInvest Partners AB 2022 Q2 filed July 8, 2022
- HealthInvest Partners AB 2022 Q1 filed May 5, 2022
- HealthInvest Partners AB 2021 Q4 filed Jan. 18, 2022
- HealthInvest Partners AB 2021 Q3 filed Nov. 8, 2021
- HealthInvest Partners AB 2021 Q2 filed Aug. 10, 2021
- HealthInvest Partners AB 2021 Q1 filed April 30, 2021
- HealthInvest Partners AB 2020 Q4 filed Feb. 5, 2021
- HealthInvest Partners AB 2017 Q4 filed Feb. 9, 2018
- HealthInvest Partners AB 2017 Q3 filed Nov. 13, 2017
- HealthInvest Partners AB 2017 Q2 filed Aug. 7, 2017